Abstract:Ferroptosis is a novel form of non-apoptotic regulated cell death (RCD), with distinct characteristics and functions in physical conditions and multiple diseases such as cancers. Unlike apoptosis and autophagy, this new RCD is an iron-dependent cell death with features of lethal accumulation of reactive oxygen species (ROS) and over production of lipid peroxidation. Excessive iron from aberrant iron metabolisms or the maladjustment of the two main redox systems thiols and lipid peroxidation role as the major causes of ROS generation, and the redox-acrive ferrous (intracellular labile iron) is a crucial factor for the lipid peroxidation. Regulation of ferrroptosis also involves different pathways such as mevalonate pathway, P53 pathway and p62-Keap1-Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway. Ferroptosis roles as a double-edged sword either suppressing or promoting tumor progression with the release of multiple signaling molecules in the tumor microenvironment. Emerging evidence suggests ferroptosis as a potential target for cancer therapy and ferroptosis inducers including small molecules and nanomaterials have been developed. The application of ferroptosis inducers also relates to overcoming drug resistance and preventing tumor metastasis, and may become a promising strategy combined with other anti-cancer therapies. Here, we summarize the ferroptosis characters from its underlying basis and role in cancer, followed by its possible applications in cancer therapies and challenges maintained.

The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Targeting Ferroptosis for Cancer Therapy: Iron Metabolism and Anticancer Immunity.

Crosstalk Between Ferroptosis and Stress—implications in Cancer Therapeutic Responses

Advances in ferroptosis of cancer therapy

The crosstalk between oncogenic signaling and ferroptosis in cancer

Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Ferroptosis and its emerging role in tumor

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Ferroptosis in cancer and cancer immunotherapy

Ferroptosis resistance in cancer: recent advances and future perspectives

Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer

Ferroptosis in life: To be or not to be

Ferroptosis as a potential target for cancer therapy

Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application